The eFACTOR Study

  • Research type

    Research Study

  • Full title

    Safety and performance evaluation of the ePATH Guided Percutaneous Re-entry device for guiding the delivery of a guidewire around a Chronic Total Occlusion of Lower Limb Artery for subsequent interventional procedures.

  • IRAS ID

    274700

  • Contact name

    Robert J Dickinson

  • Contact email

    robert.dickinson@imperial.ac.uk

  • Sponsor organisation

    Imperial College

  • ISRCTN Number

    ISRCTN82097895

  • Clinicaltrials.gov Identifier

    NA, NA

  • Duration of Study in the UK

    0 years, 7 months, 30 days

  • Research summary

    Patients with blockages in their leg arteries can be treated via special tubes called catheters. These catheters are inserted in the arteries and deliver wires to treat the blockage. If it is not possible to pierce the blockage then a wire is passed around the blockage by going inside the wall of the artery. Once past the blockage, the wire is redirected back into the artery (re-entry) to reconnect to the main blood stream. A channel that bypasses around the blockage is then made by inserting special tubes called grafts using the wire as a guide. Blood will then flow around the blockage through this graft back into the artery to reach the rest of the leg.
    Existing devices that deliver a wire around the blockage can be difficult to use and can miss the artery. This trial is to evaluate whether new devices, the ePATH Catheter Kit and Display, which use a novel method of electronic guidance, can do this more efficiently and accurately.
    The study will be performed on 10 patients from Northwick Park Hospital who need their artery unblocked and agree to participate in this research, and should take six months in total. The treatment of the blockage will remain the same as the standard treatment for the condition, except that the new ePATH devices will be used to create a channel around the blockage. The patient will not see any changes to the care given or the number of hospital visits and will leave the study after attending the usual 6 week check-up after the treatment.

  • REC name

    London - Dulwich Research Ethics Committee

  • REC reference

    20/LO/0330

  • Date of REC Opinion

    27 May 2020

  • REC opinion

    Further Information Favourable Opinion